Ron Lanton, partner, Lanton Law, warns that ongoing lawsuits targeting vaccine policy could create ripple effects across FDA ...

EMD Serono recently named Miguel Fernandez Alcalde as its new president. The new executive spoke with Pharmaceutical ...

Ron Lanton, partner, Lanton Law, warns that recent changes to federal vaccine recommendations could trigger extensive litigation as insurers, providers, and patients face new access and coverage ...

Rob Abbott, CEO, ISPOR, highlights how AI is streamlining research and improving patient care while stressing the importance of human oversight.

Why pharma and all stakeholders in the healthcare ecosystem should undertake a fundamental shift in how evidence to support ...

The disease doesn’t have any FDA approved treatments, leaving families desperate for FDA to approve the treatment.

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Pharma can embrace product iteration over one-time launches—and enhance agility and responsiveness through effective roadmaps ...